T.RVX
|
Well, that creates a very interesting situation. If June 3rd is the effective...
|
T.RVX
|
It is now clear that one can buy on May 31st and still be included, based on...
|
T.RVX
|
You are right! My apologies for my previous mistake. Here is the excerpt from...
|
T.RVX
|
From this excerpt from the arrangement circular below, it sounds like the...
|
T.RVX
|
I agree with bromodomain. Last day to buy is May 28th if you want to settle...
|
T.RVX
|
Keep in mind that in this paper, they used mice genetically engineered to...
|
T.RVX
|
"Not that they necessarily know for sure, but note what they say goes...
|
T.RVX
|
Perhaps there are some that are selling today to #1 pocket some gains, but...
|
T.RVX
|
Which carries more weight for negotiating a sale of RVX to big pharma...
|
T.RVX
|
However, we give up our Resverlogix Royalty Preferred Shares as part of the...
|
T.RVX
|
Windy, I think the language int he arrangement reads "net apoAI revenue...
|
T.RVX
|
Sorry. It should be 6-12% range, not 6-10% range.
|
T.RVX
|
If and when RVX is sold to big pharma, and if and when RVX-208 hits the...
|
T.RVX
|
IMO, Dr. Wong and Dr. Nissen are going to reveal something new at their...
|
T.RVX
|
Until the anticipated end of June release of top-line ASSURE trial data...
|
T.RVX
|
Until the anticipated end of June release of top-line ASSURE trial data...
|
T.RVX
|
Until the anticipated end of June release of top-line ASSURE trial data...
|
T.RVX
|
Yahoo finance has had this same $6.50 projection for RVX ever since I first...
|
T.RVX
|
I doubt if anything new was presented at the Biopharma investor conferences...
|
T.RVX
|
Sorry bromodomain. I think you have it wrong. Page 17 of the investor...
|